VIR Vir Biotechnology, Inc.
Price Chart
Executive Summary
Vir Biotechnology's Chief Medical Officer, Mark Eisner, is stepping down effective April 24, 2026, and the company has begun a search for his successor. This is a C-suite departure but no immediate replacement was named.
Actionable Insight
Monitor for updates on the CMO search and any interim leadership assignments, particularly given Vir's focus on clinical-stage biologics. The departure may prompt investor questions about continuity in medical strategy.
Key Facts
- Dr. Mark Eisner, Executive Vice President and Chief Medical Officer, is stepping down effective April 24, 2026.
- He informed the company of his departure on April 7, 2026.
- The company has initiated a search for a successor but has not named an interim or permanent replacement.
- No reason for departure was specified beyond 'stepping down'.
Financial Impact
No direct financial impact disclosed; potential for near-term operational uncertainty in clinical development leadership.
Risk Factors
- Potential disruption in clinical development leadership during transition
- Increased scrutiny on management stability given recent insider selling
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-151209 |
| Document: 0001193125-26-151209-index-headers.html | 0001193125-26-151209 |
| Document: 0001193125-26-151209-index.html | 0001193125-26-151209 |
| Document: 0001193125-26-151209.txt | 0001193125-26-151209 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
2d ago
|
3
| $8.25 awaiting T+1 | awaiting T+1 | — | $8.61 (+4.36%) |
|
Jun 10, 2026
2d ago
|
8-K
| $8.25 awaiting T+1 | awaiting T+1 | — | $8.61 (+4.36%) |
|
Jun 2, 2026
10d ago
|
Insider Cluster
| $8.77 $9.15 | ▲ +4.33% | ▲ +3.93% | $8.61 (−1.82%) |
|
May 28, 2026
15d ago
|
8-K
| $9.55 $9.54 | ▼ −0.10% | ▼ −0.34% | $8.61 (−9.84%) |
|
Apr 16, 2026
8w ago
|
DEFA14A
| $10.33 $10.75 | ▲ +4.07% | ▲ +2.85% | $8.61 (−16.65%) |
|
Apr 10, 2026
9w ago
|
8-K
| $9.31 $10.05 | ▲ +7.95% | ▲ +6.74% | $8.61 (−7.52%) |
|
Apr 1, 2026
10w ago
|
Insider Cluster
| $9.02 $9.06 | ▼ −0.44% | ▼ −0.36% | $8.61 (+4.55%) |
|
Mar 4, 2026
14w ago
|
8-K
| $9.10 $9.55 | ▲ +4.95% | ▲ +6.26% | $8.61 (−5.38%) |
|
Feb 24, 2026
15w ago
|
Insider Cluster
| $9.49 $10.00 | ▼ −5.37% | ▼ −4.54% | $8.61 (+9.27%) |
|
Feb 23, 2026
15w ago
|
Insider Cluster
| $7.43 $9.49 | ▼ −27.73% | ▼ −26.99% | $8.61 (−15.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access